Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 9
2004 4
2005 2
2006 3
2007 7
2008 5
2009 2
2010 4
2011 7
2012 8
2013 4
2014 4
2015 9
2016 3
2017 9
2018 11
2019 12
2020 15
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

111 results
Results by year
Filters applied: . Clear all
Page 1
Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers.
Ogiwara H, Takahashi K, Sasaki M, Kuroda T, Yoshida H, Watanabe R, Maruyama A, Makinoshima H, Chiwaki F, Sasaki H, Kato T, Okamoto A, Kohno T. Ogiwara H, et al. Among authors: takahashi k. Cancer Cell. 2019 Feb 11;35(2):177-190.e8. doi: 10.1016/j.ccell.2018.12.009. Epub 2019 Jan 24. Cancer Cell. 2019. PMID: 30686770 Free article.
Vaginal Transmission of Cancer from Mothers with Cervical Cancer to Infants.
Arakawa A, Ichikawa H, Kubo T, Motoi N, Kumamoto T, Nakajima M, Yonemori K, Noguchi E, Sunami K, Shiraishi K, Kakishima H, Yoshida H, Hishiki T, Kawakubo N, Kuroda T, Kiyokawa T, Yamada K, Yanaihara N, Takahashi K, Okamoto A, Hirabayashi S, Hasegawa D, Manabe A, Ono K, Matsuoka M, Arai Y, Togashi Y, Shibata T, Nishikawa H, Aoki K, Yamamoto N, Kohno T, Ogawa C. Arakawa A, et al. Among authors: takahashi k. N Engl J Med. 2021 Jan 7;384(1):42-50. doi: 10.1056/NEJMoa2030391. N Engl J Med. 2021. PMID: 33406329
Therapeutic preferability of gemcitabine for ARID1A-deficient ovarian clear cell carcinoma.
Kuroda T, Ogiwara H, Sasaki M, Takahashi K, Yoshida H, Kiyokawa T, Sudo K, Tamura K, Kato T, Okamoto A, Kohno T. Kuroda T, et al. Among authors: takahashi k. Gynecol Oncol. 2019 Dec;155(3):489-498. doi: 10.1016/j.ygyno.2019.10.002. Epub 2019 Oct 8. Gynecol Oncol. 2019. PMID: 31604667
Rethinking of treatment strategies and clinical management in ovarian clear cell carcinoma.
Takahashi K, Takenaka M, Kawabata A, Yanaihara N, Okamoto A. Takahashi K, et al. Int J Clin Oncol. 2020 Mar;25(3):425-431. doi: 10.1007/s10147-020-01625-w. Epub 2020 Jan 27. Int J Clin Oncol. 2020. PMID: 31989349 Review.
A multi-center retrospective study of neuroendocrine tumors of the uterine cervix: Prognosis according to the new 2018 staging system, comparing outcomes for different chemotherapeutic regimens and histopathological subtypes.
Ishikawa M, Kasamatsu T, Tsuda H, Fukunaga M, Sakamoto A, Kaku T, Kato T, Takahashi K, Ariyoshi K, Suzuki K, Arimoto T, Matsumoto Y, Nakai H, Inoue T, Yokoyama M, Kawabata T, Kodama S, Miyamoto T, Takano M, Yaegashi N. Ishikawa M, et al. Among authors: takahashi k. Gynecol Oncol. 2019 Dec;155(3):444-451. doi: 10.1016/j.ygyno.2019.09.018. Epub 2019 Oct 18. Gynecol Oncol. 2019. PMID: 31635755
Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patients.
Hirose S, Murakami N, Takahashi K, Kuno I, Takayanagi D, Asami Y, Matsuda M, Shimada Y, Yamano S, Sunami K, Yoshida K, Honda T, Nakahara T, Watanabe T, Komatsu M, Hamamoto R, Kato MK, Matsumoto K, Okuma K, Kuroda T, Okamoto A, Itami J, Kohno T, Kato T, Shiraishi K, Yoshida H. Hirose S, et al. Among authors: takahashi k. Gynecol Oncol. 2020 Jan;156(1):203-210. doi: 10.1016/j.ygyno.2019.10.022. Epub 2019 Nov 19. Gynecol Oncol. 2020. PMID: 31757465
Effect of gut microflora on nutritional availability of selenium.
Takahashi K, Suzuki N, Ogra Y. Takahashi K, et al. Food Chem. 2020 Jul 30;319:126537. doi: 10.1016/j.foodchem.2020.126537. Epub 2020 Mar 2. Food Chem. 2020. PMID: 32193059
A matricellular protein fibulin-4 is essential for the activation of lysyl oxidase.
Noda K, Kitagawa K, Miki T, Horiguchi M, Akama TO, Taniguchi T, Taniguchi H, Takahashi K, Ogra Y, Mecham RP, Terajima M, Yamauchi M, Nakamura T. Noda K, et al. Among authors: takahashi k. Sci Adv. 2020 Nov 25;6(48):eabc1404. doi: 10.1126/sciadv.abc1404. Print 2020 Nov. Sci Adv. 2020. PMID: 33239290 Free PMC article.
Very low prevalence of anti-HAV in Japan: high potential for future outbreak.
Yamamoto C, Ko K, Nagashima S, Harakawa T, Fujii T, Ohisa M, Katayama K, Takahashi K, Okamoto H, Tanaka J. Yamamoto C, et al. Among authors: takahashi k. Sci Rep. 2019 Feb 6;9(1):1493. doi: 10.1038/s41598-018-37349-1. Sci Rep. 2019. PMID: 30728377 Free PMC article.
MicroRNA-34a/IL-6R pathway as a potential therapeutic target for ovarian high-grade serous carcinoma.
Yokomizo R, Yanaihara N, Yamaguchi N, Saito M, Kawabata A, Takahashi K, Takenaka M, Yamada K, Shapiro JS, Okamoto A. Yokomizo R, et al. Among authors: takahashi k. Oncotarget. 2019 Aug 6;10(47):4880-4893. doi: 10.18632/oncotarget.27117. eCollection 2019 Aug 6. Oncotarget. 2019. PMID: 31448054 Free PMC article.
111 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback